Home FTC accuses Endo, other drugmakers of antitrust violations
 

Keywords :   


FTC accuses Endo, other drugmakers of antitrust violations

2016-03-31 20:45:52| Biotech - Topix.net

The Federal Trade Commission is accusing several drugmakers of violating antitrust laws with agreements that delayed availability of cheaper generic versions of two pain treatments. It's the first so-called "pay for delay" case brought by the commission in which a drug's original maker agreed not to sell an "authorized generic" version until well after a generic drugmaker launched its product.

Tags: violations endo antitrust ftc

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11L
26.11 2019 BBM10
26.11Disney/Pixar Spooky Night
26.11 33
26.1114
26.11[272] ELMA03
26.113D
26.11CORRATEC R.T 3 2way-Fit
More »